Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10312572" target="_blank" >RIV/00216208:11110/15:10312572 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/15:10312572 RIV/00216208:11160/15:10312572 RIV/61989592:15110/15:33156031 RIV/00179906:_____/15:10312572 RIV/00023728:_____/15:#0005003
Result on the web
<a href="http://www.tandfonline.com/doi/full/10.3109/13697137.2014.995164" target="_blank" >http://www.tandfonline.com/doi/full/10.3109/13697137.2014.995164</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3109/13697137.2014.995164" target="_blank" >10.3109/13697137.2014.995164</a>
Alternative languages
Result language
angličtina
Original language name
Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter
Original language description
Objectives Low adherence to treatment with bisphosphonates significantly impedes its effectiveness. The objectives were: (1) to compare adherence to oral weekly and monthly bisphosphonates with emphasis on dosing instructions; and (2) to study associations between adherence and beliefs about the bisphosphonate treatment among women >= 55 years. Methods A multicenter survey was performed in secondary-care patients with osteoporosis. Osteoporosis Specific Morisky Medication Adherence Scale (OS-MMAS), questions on compliance with five dosing instructions and Beliefs about Medicines Questionnaire (BMQ) Specific were used. Results As many as 363 questionnaires (response rate 95%) were analyzed. Respondents (mean age 69 years) were treated with weekly bisphosphonates (37%) or monthly ibandronate (63%). Based on OS-MMAS, 67% of respondents showed high adherence with no differences between the subgroups. Only 44% of respondents were compliant with all dosing instructions. Compliance with dosin
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Climacteric
ISSN
1369-7137
e-ISSN
—
Volume of the periodical
18
Issue of the periodical within the volume
4
Country of publishing house
GB - UNITED KINGDOM
Number of pages
9
Pages from-to
608-616
UT code for WoS article
000359844900025
EID of the result in the Scopus database
2-s2.0-84932139663